Big coffee depth analysis! In the AI era, how to use patent intelligence to empower efficient research and development.
Release time:
2024-04-26 14:15
At 10: 00 a.m. on April 24, the 24th "World Intellectual Property Week" Hua Xun joined hands with Wisdom Bud to discuss "How to Make Good Use of Patent Information to Enabling Efficient Research and Development in AI Era". The online live broadcast forum was successfully held.
This event is sponsored by Nanjing Jiangbei New District Industrial Technology Research Park, Huaxun. International intellectual property and foreign-related legal service platform, Nanjing Huaxun intellectual property Consulting Co., Ltd., Taiwan Qingchen Law firm's representative office in Nanjing, Jiance intellectual property Consulting Nanjing Co., Ltd., co-sponsored by Wisdom Bud.
This activity strongly invites four industry experts to jointly discuss and exchange learning AI era, how to make good use of patent information to enable efficient research and development, from "why" to "how to do", to break through the research and development dilemma with enterprises, and to help enterprises take the first step to break the situation!
Dr. Hou Qingchen, founder of Nanjing Huaxun Intellectual Property Consulting Co., Ltd./executive partner of Qingchen Law Firm, talked about "the legal issues brought by AI" from "What is AI?", and also discussed the legal attributes of artificial intelligence, including whether AI can become the subject of legal rights, AI's ability to act, and the ownership of AI's creative intellectual property rights.
Dr. Yufeng Wei, founder and CEO of Vizuro LLC with more than 25 years of industry experience, sharedIt introduces the application of AI in new drug development, including market trends, investment, current challenges and unmet needs, new trends and case studies.
Teacher Ang Zhengxin, head of high-tech business in Su-Wan District of Wisdom Bud, detailsThis paper introduces how Smart Bud can help enterprises simplify the innovation process and improve the efficiency of research and development through AI technology, and how to use AI to monitor technical intelligence and prevent risks.
At the end of the activity, Mr. Zheng Chenyu, senior technology and patent litigation expert of Yamamoto Chartered Law Firm/Jiance Intellectual Property Consultant Nanjing Co., Ltd.This paper introduces the application of AI in drug research and development, including the role of shortening the development cycle and reducing risks, as well as the companies and financing related to AI-assisted drug research and development. At the same time, it also discusses the precautions of Japanese patent applications and the intellectual property issues faced by AI pharmaceutical companies in the patent layout.
In the intellectual property industry, Huaxun has been providing high-quality and professional comprehensive intellectual property services for enterprises and universities step by step, hoping to contribute to the construction of China's intellectual property power under the leadership of the state and the government.
Playback Link:
https://v.youku.com/v_show/id_XNjM5MTQxNjkyMA==.html